INDICE: Chapter 1: Introduction to Brain Stimulation Provide an outline of the book, including a section on medication resistance. Writer – Irving Reti (Johns Hopkins University, Baltimore, MD), possibly with Frank Mondimore (Johns Hopkins University, Baltimore, MD) A. BRAIN CIRCUITRY AND PLASTICITY Chapter 2: The mood and motivation pathways Describe the brain regions regulating mood and motivation including the preclinical and clinical evidence for these pathways. Include a focus on the role of the medial prefrontal cortex in the antidepressant response and the role of the same in addiction. Possible writers – Damiaan Denys (University of Amsterdam, Amsterdam, The Netherlands), Susan Haber (University of Rochester, Rochester, NY), Helen Mayberg (Emory University, Atlanta, GA) Chapter 3: The motor pathways Describe the brain regions regulating motor activity including the preclinical and clinical evidence for these pathways. Possible writers – Mahlon Delong and Thomas Wichmann (Emory University, Atlanta, GA), Erwin Montgomery (University of Alabama, Alabama), Hagai Bergman (Hebrew University, Jerusalem, Israel) Chapter 4: Activity dependent neuronal plasticity Focus on how neuronal activity can lead to long–lasting changes in neural transmission, especially changes at the synapse. Outline these changes and how brain stimulating modalities can trigger them. Writer – Jay Baraban (Johns Hopkins University, Baltimore, MD); Dr. Baraban has already agreed to write this chapter, however Eric Nestler (Mount Sinai School of Medicine, New York, NY) or Paul Worley (Johns Hopkins University, Baltimore, MD) would be alternates. B. TECHNOLOGY (1) NON–INVASIVE (a) Convulsive Chapter 5: Introduction to convulsive therapy Include basic facts about ECT and the history of convulsive therapy dating back to observations in antiquity about the therapeutic effects of seizure. Also include mention of magnetic seizure therapy (MST) and focal electrically administered seizure therapy. Possible writers – Frank Mondimore (Johns Hopkins University, Baltimore, MD), Punit Vaidya (Cleveland VA Medical Center, Cleveland, OH), Sarah Lisanby (Duke University, Durham, NC) Chapter 6: How does electroconvulsive therapy work? Review possible mechanisms underlying the therapeutic effects of ECT. Also review possible mechanisms underlying cognitive side–effects associated with ECT. Writer – Irving Reti (Johns Hopkins University, Baltimore, MD) Chapter 7: Improving ECT efficacy and decrease cognitive side–effects Present the latest data pertaining to ECT efficacy and cognitive side–effects focused on electrode placement and charge dosing, pulsewidth, adjunctive antidepressants during ECT and anesthesia regimes. Possible writers – Colleen Loo (University of New South Wales, Sydney, Australia), Charles Kellner (Mount Sinai School of Medicine, New York, NY), Pascal Sienart (Catholic University Leuven, Kortenberg, Belgium) Chapter 8: Magnetic seizure therapy for the treatment of depression Review the latest data on efficacy and cognitive side–effects. Include a section on coil design. Possible writers – Sarah Lisanby (Duke University, Durham, NC), Mustafa Husain (University of Texas Southwestern Medical Center, Dallas,TX), Thomas Schlaepfer (University of Bonn, Bonn, Germany) (b) Non–convulsive Chapter 9: Introduction to non–convulsive brain stimulation Include sections on: A brief history of and introduction to non–convulsive brain stimulation technologies focused on the development of these technologies as tools to probe normal and abnormal brain function (including cognition, perception and motor function) with later interest in their therapeutic effects; mostly focus on TMS (including basic physics, single pulse, paired pulses for facilitation or inhibition, repetitive TMS and theta burst stimulation (TBS)), although also include mention of electrical stimulation and other more experimental non–convulsive stimulation modalities such as ultrasound and infrared. Possible writers – Sarah Lisanby (Duke University, Durham, NC), Moacyr Rosa (Federal University of Sao Paulo, Sao Paolo, Brazil), John Rothwell (University College London, London, England), Vince Walsh (University College London, London, England), Jeff Daskalakis (CAMH, University of Toronto, Toronto, Canada) Chapter 10: Advances in TMS coil technology Include a section on stimulator design but mostly focus on coil design including circular, double cone, figure–of–8 and H–coil coils and how they affect electric field focality and depth attenuation as determined by modeling. Also describe coil cooling systems and TMS–MRI and TMS–EEG set–ups. Include clinical data pertaining to coils and compare with data for the standard figure–of–8 coil. Possible writers – Angel Peterchev (Duke University, Durham, NC), Zhi–De Deng (Duke University, Durham, NC or Columbia University, New York, NY), Anthony Barker (University of Sheffield, England), Abraham Zangen (Weizmann Institute of Science, Rehovot, Israel) Chapter 11: Applications of TMS in the field of brain connectivity Include sections on: Introduction to brain connectivity including currently available tools for monitoring it such as fMRI, other functional imaging, EEG and motor evoked potential; how TMS can assist in measuring brain connectivity; how TMS can be used to manipulate brain connectivity; potential clinical application, namely targeting TMS based on the connectivity of an individual who is suffering with a disease. Possible writers – Alvaro Pascual–Leone (Beth Israel Deaconess Medical Center, Boston, MA), Mark George (Medical University of South Carolina, Charleston, SC), John Desmond (Johns Hopkins University, Baltimore, MD), Tomas Paus (University of Toronto, Toronto, Canada) Chapter 12: Therapeutic applications of TMS for psychiatric and neurological conditions Include sections on: Depression (including accelerated TMS, low frequency stimulation over the right DLPFC (LFR), neuronavigation, priming, TBS, patient selection), bipolar disorder, anxiety disorders including PTSD with emphasis on LFR, OCD, schizophrenia, movement disorders especially Parkinson’s disease, pain, tinnitus, migraine, traumatic brain injury, stroke and neurorehabilitation. Possible writers – Mark George (Medical University of South Carolina, Charleston, SC), Alvaro Pascual–Leone (Beth Israel Deaconess Medical Center, Boston, MA), Jeff Daskalakis (CAMH, University of Toronto, Toronto, Canada), Paul Fitzgerald (Monash University, Melbourne, Australia) Chapter 13: Transcranial direct current stimulation: modulation of brain pathways and potential clinical applications Include sections on: Development of tDCS as a non–invasive tool to induce neuroplasticity in the human cerebral cortex for investigating cognition and other higher order functions; potential clinical applications. Possible writers – Andrea Antal, Walter Paulus, Michael Nitsche (all of the University of Gottingen, Gottingen, Germany), Frank Padberg (Ludwig–Maximilian University, Munich, Germany), David Schretlen (Johns Hopkins University, Baltimore, MD) (2) INVASIVE Chapter 14: Introduction to invasive brain stimulation Include sections on: invasive brain stimulation techniques including DBS and VNS as well as implanted cortical stimulation (ICS) for chronic pain and possibly depression; conditions where surgery (including even lobotomy) was formerly the approach but where invasive stimulation is now being used instead eg refractory epilepsy, OCD, depression; ethical considerations associated with invasive brain stimulation. Writer – Ziad Nahas (American University, Beirut, Lebanon); Dr. Nahas has already agreed to write this chapter, but many of the writers listed below for the other chapters could be alternates Chapter 15: Neurological indications for DBS Include sections on: DBS for Parkinson’s disease, tremor, dystonia, Tourette syndrome, epilepsy and intractable pain; tie effectiveness of the treatment of the various conditions to neuroanatomy and the neurophysiological effects of DBS; generic neurosurgical issues related to DBS including surgical technique, types of electrodes and complications, including hitting the wrong site. Possible writers – Stan Anderson (Johns Hopkins University, Baltimore, MD), Fred Lenz (Johns Hopkins University, Baltimore, MD), Andres Lozano (University of Toronto, Toronto, Canada) Chapter 16: Psychiatric indications for DBS Include sections on: DBS for OCD, depression, drug addiction, Alzheimer’s disease, schizophrenia; the evidence for efficacy for each condition including details about stimulation sites and parameter settings; adverse effects including hitting the wrong site. Possible writers – Helen Mayberg (Emory University, Atlanta, GA), Paul Holtzheimer (Dartmouth Medical School, Hanover, NH), Ben Greenberg (Brown University, Providence, RI), Damiaan Denys (University of Amsterdam, Amsterdam, The Netherlands), Donald Malone (Cleveland Clinic, Cleveland, OH) Chapter 17: VNS for epilepsy and depression Review efficacy and safety data for VNS for both epilepsy and depression. Discuss possible mechanisms of action. Possible writers – for epilepsy consider Robert Fisher (Stanford University, Stanford, California), Steven Schachter (Harvard Medical School, Boston, MA. For depression consider Charles Conway (Washington University, St Louis, MO), Linda Carpenter (Brown University, Providence, RI)
- ISBN: 978-1-118-56829-3
- Editorial: Wiley–Blackwell
- Encuadernacion: Cartoné
- Páginas: 350
- Fecha Publicación: 19/06/2014
- Nº Volúmenes: 1
- Idioma: Inglés